Rafoxanide and Impurities
Rafoxanide
Controlled ProductCAS:22662-39-1
Formula:
C19H11Cl2I2NO3
Color and Shape:
Neat
Molecular weight:
626.01
Ref: 86-MM0363.00
250mg | 303.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
Ref: 4Z-R-691
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Ref: 4Z-R-693
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Ref: 4Z-R-692
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Rafoxanide
CAS:22662-39-1
Rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer.
Formula:
C19H11Cl2I2NO3
Purity:
99.47%
Color and Shape:
Slight Yellowish Brown Injectable Solution &White Oral Solution
Molecular weight:
626.01
Ref: TM-T7093
1g | 97.00 € | ||
500mg | 63.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024